AU7165798A - Use of genistein and related compounds to treat certain sex hormone related conditions - Google Patents

Use of genistein and related compounds to treat certain sex hormone related conditions

Info

Publication number
AU7165798A
AU7165798A AU71657/98A AU7165798A AU7165798A AU 7165798 A AU7165798 A AU 7165798A AU 71657/98 A AU71657/98 A AU 71657/98A AU 7165798 A AU7165798 A AU 7165798A AU 7165798 A AU7165798 A AU 7165798A
Authority
AU
Australia
Prior art keywords
genistein
sex hormone
treat certain
certain sex
related compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71657/98A
Inventor
Jack Geller
Dusan Miljkovic
Gordana Olbina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anticancer Inc
Original Assignee
Anticancer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anticancer Inc filed Critical Anticancer Inc
Publication of AU7165798A publication Critical patent/AU7165798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
AU71657/98A 1997-04-28 1998-04-28 Use of genistein and related compounds to treat certain sex hormone related conditions Abandoned AU7165798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84854097A 1997-04-28 1997-04-28
US08848540 1997-04-28
PCT/US1998/008484 WO1998048790A1 (en) 1997-04-28 1998-04-28 Use of genistein and related compounds to treat certain sex hormone related conditions

Publications (1)

Publication Number Publication Date
AU7165798A true AU7165798A (en) 1998-11-24

Family

ID=25303571

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71657/98A Abandoned AU7165798A (en) 1997-04-28 1998-04-28 Use of genistein and related compounds to treat certain sex hormone related conditions

Country Status (2)

Country Link
AU (1) AU7165798A (en)
WO (1) WO1998048790A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
US6576660B1 (en) * 1997-10-31 2003-06-10 Arch Development Corporation Methods and compositions for regulation of 5-α-reductase activity
US5958946A (en) * 1998-01-20 1999-09-28 Styczynski; Peter Modulation of hair growth
AUPP260798A0 (en) 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
KR20010080692A (en) 1998-12-07 2001-08-22 스티븐 엠. 베셋트 Cancer Treatment Composition and Method Using Natural Plant Essential Oils
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
GB2361642A (en) * 2000-10-24 2001-10-31 Karobio Ab Estrogen receptor beta (ERbeta) agonists for use in cancer treatment
AUPR363301A0 (en) 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
PL205635B1 (en) * 2001-04-09 2010-05-31 Inst Farmaceutyczny Novel derivatives of genistein and pharmacological agents containing such derivatives
SE0101697D0 (en) * 2001-05-14 2001-05-14 Astrazeneca Ab Pharmaceutical combination
EP1808172A3 (en) * 2002-03-06 2010-05-26 Activephyto Technologies Limited Botanical extract compositions and methods of use
ATE361746T1 (en) * 2002-03-06 2007-06-15 Medical Res And Education Trus BOTANICAL EXTRACT WITH ANTI-CANCER ACTIVITY CONTAINING ISOLIQUIRITIGENIN
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
WO2004039327A2 (en) * 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
AU2003259220C1 (en) 2002-07-24 2017-08-24 Australian Health & Nutrition Association Limited Compositions and products containing enantiomeric equol, and methods for their making
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
US8680140B2 (en) * 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
TWI366565B (en) 2007-06-06 2012-06-21 Otsuka Pharma Co Ltd Quinolone compound and pharmaceutical composition
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
WO2009026657A1 (en) * 2007-08-29 2009-03-05 The University Of Sydney Flavonoid ppar agonists
WO2009049214A2 (en) * 2007-10-12 2009-04-16 Northwestern University Inhibition and treatment of prostate cancer metastasis
TWI472525B (en) 2008-12-05 2015-02-11 Otsuka Pharma Co Ltd Quinolone compound and pharmaceutical composition
CN113214211B (en) * 2021-04-23 2022-04-22 广东药科大学 Compound extracted from peony bark charcoal and preparation method and pharmaceutical application thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61246124A (en) * 1985-04-24 1986-11-01 Yamanouchi Pharmaceut Co Ltd Carcinostatic agent
JPH0196124A (en) * 1987-10-07 1989-04-14 Fujirebio Inc Carcinostatic agent
JPH085788B2 (en) * 1987-10-08 1996-01-24 花王株式会社 5α-reductase inhibitor
AU683838B2 (en) * 1992-05-19 1997-11-27 Novogen Research Pty Ltd Health supplements containing phyto-oestrogens, analogues or metabolites thereof
US5587459A (en) * 1994-08-19 1996-12-24 Regents Of The University Of Minnesota Immunoconjugates comprising tyrosine kinase inhibitors
US5911995A (en) * 1994-08-19 1999-06-15 Regents Of The University Of Minnesota EGF-genistein conjugates for the treatment of cancer
DE4432947C2 (en) * 1994-09-16 1998-04-09 New Standard Gmbh Agent for the treatment of the skin and its use
WO1996039832A1 (en) * 1995-06-07 1996-12-19 Kung Patrick C Compounds and methods for promoting hair growth
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses

Also Published As

Publication number Publication date
WO1998048790A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
AU7165798A (en) Use of genistein and related compounds to treat certain sex hormone related conditions
HK1034189A1 (en) An acidified composition for topical treatment of nail and skin conditions.
IL116479A0 (en) Antifungal compositions and bandage for treatment of nails
AU1721697A (en) Use of compositions comprising stabilized biologically effective compounds
GB0015235D0 (en) Compositions for the treatment of skin and anorectal conditions
EP1073416A4 (en) Use of inhaled no as anti-inflammatory agent
AU3684895A (en) Use of human chorionic gonadotropin as an immune-potentiating agent
ZA975267B (en) Preparation of fungicidal quinazolinones and useful intermediates
AU1773600A (en) Topical treatment of skin disease
AU2340397A (en) Use of nicotine to treat liver disease
AU5083098A (en) Use of leptin to stimulate hematopoiesis
PL336760A1 (en) Treatment of skin diseases
AU4945297A (en) Pyrazolinones to treat disturbances of potency
EP1011689B8 (en) USE OF 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
AU1295099A (en) Water repellent restorative and process of use
AU2003204844A1 (en) Use of methylnaltrexone and related compounds
AU1228499A (en) Application of tnf antagonists as medicaments for treating septic diseases
AU9756898A (en) Human prostaglandin receptors and methods of use thereof
AU4759397A (en) Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
ZA989514B (en) Treatment of diabetic retinopathy
EP0845990A4 (en) New use of pregnane-diones as analgesic agents
ZA97253B (en) Topical compositions for the treatment of skin diseases
GB2324962B (en) Treatment of allergic conditions
GB9709451D0 (en) Treatment of allergic conditions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase